Gilleron J, Gerdes JM, Zeigerer A. Metabolic regulation through the endosomal system. Traffic. 2019;20:552--570. 10.1111/tra.12670 31177593

**Funding information** Agence Nationale de Recherches, Grant/Award Number: ANR18‐CE14‐0035‐01‐GILLERON; Bundesministerium für Bildung und Forschung, Grant/Award Number: 031L0114A; Deutsche Forschungsgemeinschaft, Grant/Award Numbers: ZE1037/1‐1, ZE1037/3‐1; European Foundation for the Study of Diabetes, Grant/Award Number: 01KU1501C; DZD, Grant/Award Number: 920.561‐82DZD0032G

The copyright line for this article was changed on 14 August 2019 after original online publication.

1. INTRODUCTION {#tra12670-sec-0001}
===============

The role of the endosomal system in maintaining cellular homeostasis has been studied for decades and has provided us with a deep appreciation for its complexity, specificity and functionality.[1](#tra12670-bib-0001){ref-type="ref"}, [2](#tra12670-bib-0002){ref-type="ref"}, [3](#tra12670-bib-0003){ref-type="ref"}, [4](#tra12670-bib-0004){ref-type="ref"} This homeostasis is mediated by a highly interconnected network of compartments that regulate cellular signaling, nutrient sensing and transport, cell polarity and cell migration. The dynamic interaction between the endosomal compartments enables the amount and spatial distribution of more than 5000 integral membrane proteins to be controlled.[5](#tra12670-bib-0005){ref-type="ref"}, [6](#tra12670-bib-0006){ref-type="ref"} This function is accomplished by numerous endosomal multi‐protein complexes that regulate the amount of protein on the plasma membrane depending on the physiological condition by sending them to lysosomes for degradation or routing them back to the plasma membrane for recycling. Many elegant studies have unraveled the functions of the endosomal network within cellular systems. However, we have very limited knowledge on how these functions relate to the role of cells in tissues, organs and whole organism physiology.

Interestingly, recent findings have begun to support a role for the endosomal system in metabolic homeostasis. For instance, reduction of the endo‐lysosomal compartments in the liver through knockdown of the small GTPase Rab5 was sufficient to induce a severe metabolic phenotype,[7](#tra12670-bib-0007){ref-type="ref"}, [8](#tra12670-bib-0008){ref-type="ref"} normally only achieved through interference with metabolically relevant genes. This rapid and profound effect of Rab5 knockdown places the endosomal system into the regulatory network of glucose and lipid metabolism. Although these results might have been surprising, data in humans with metabolic diseases already show that mutations in endosomal genes are associated with metabolic pathologies, such as type 2 diabetes, hypercholesterolemia and non‐alcoholic fatty liver disease (NAFLD).[9](#tra12670-bib-0009){ref-type="ref"}, [10](#tra12670-bib-0010){ref-type="ref"}, [11](#tra12670-bib-0011){ref-type="ref"}, [12](#tra12670-bib-0012){ref-type="ref"}, [13](#tra12670-bib-0013){ref-type="ref"}, [14](#tra12670-bib-0014){ref-type="ref"}, [15](#tra12670-bib-0015){ref-type="ref"}, [16](#tra12670-bib-0016){ref-type="ref"}, [17](#tra12670-bib-0017){ref-type="ref"} These recent findings highlight a wider function of the endosomal system at an organism level and provide us with a possibility to connect and translate our fundamental knowledge on endocytosis to metabolic (patho‐) physiologies. In light of the increasing pandemics of type 2 diabetes and obesity, which will collectively affect 2 billion people worldwide by 2040 (WHO), this research could also reveal potential new targets for therapeutic interventions.

A key feature of type 2 diabetes is the dysregulation of metabolic homeostasis. This is characterized by an imbalance between nutrient intake, storage and consumption. Under physiological conditions, metabolically active organs, such as muscle, fat, liver, pancreas and brain store nutrients upon food intake by turning on anabolic processes, such as glycogen and fatty acid synthesis and glycolysis, and by repressing catabolic processes, such as gluconeogenesis (glucose production), glycogenolysis and fatty acid oxidation (Figure [1](#tra12670-fig-0001){ref-type="fig"}). When nutrient availabilities are low during fasting, these responses are inverted to ensure sufficient energy supplies for the body (Figure [2](#tra12670-fig-0002){ref-type="fig"}). The switch between fasting and feeding is mainly regulated by the hormones glucagon and insulin, where insulin is responsible for anabolic processes. This metabolic regulation is perturbed in type 2 diabetes, where constant food intake and endogenous energy production lead to a permanent increase in blood glucose levels (hyperglycemia) and insulin resistance. Thus, the maintenance of metabolic homeostasis requires proper sensing of insulin and glucagon signals and differential interpretation of those signals in different tissues. For instance, insulin induces glucose uptake in muscle and fat, but represses glucose production in liver (see below). In addition, the expression of nutrient transporters on the plasma membrane to mediate the uptake of glucose, low density lipoprotein‐cholesterol (LDL‐C), free fatty acids, etc. needs to be modulated in target tissues depending on nutrient availabilities. This implies a requirement for fine‐tuned regulation of transporter recycling vs degradation. Plasma membrane plasticity is essential for internalization of receptors but also for secretion of insulin granules, for instance, in the pancreas. These different requirements for signal transduction, nutrient transport, receptor degradation and induced recycling are all hallmarks of the endosomal system.

![Involvement of endocytic components in systemic metabolism in the postprandial (feeding) period. After a meal, circulating blood glucose levels rise, leading to a massive entry of glucose into pancreatic β‐cells via the glucose transporter GLUT2, which causes the release of insulin into the blood stream. The cell surface amounts of GLUT2 are maintained constant via recycling of GLUT2. Adipocytes, the main cell type of adipose tissue, sense the increase in circulating insulin levels resulting in an induction of p‐AKT‐dependent signaling cascades that favor the fusion of GLUT4 storage vesicles with the plasma membrane, increasing the surface expression of GLUT4. When GLUT4 is translocated at the cell surface, glucose will enter into adipocytes and be stored as triglycerides within the lipid droplets. Concomitantly, insulin acts on the main liver cells, hepatocytes, by inducing a cascade of signaling events downstream of the insulin receptor. These signals will restructure the genomic program of the hepatocytes towards anabolic processes, either storing glucose that enters the cells in a concentration‐dependent manner via GLUT2 into glycogen, or utilizing the glucose for glycolysis. In addition to controlling glucose levels, hepatocytes also participate in the regulation of cholesterol levels. To achieve this function, circulating low‐density lipoprotein cholesterol (LDL‐C) is taken up by the hepatocytes and sent to lysosomes, where the digested cholesterol will be extracted via the Niemann‐Pick proteins into the cytosol. Cytosolic cholesterol can then be used either for incorporation into membranes or for bile acid production. Examples of endocytic components that play a role in these metabolic processes are labeled in red. EE, early endosomes; ERC, endosomal recycling compartment; GSVs, GLUT4 storage vesicles; ISGs, insulin secretory vesicles; LYS, lysosome; TG, triglycerides; IR, insulin receptor; LDLR, LDL receptor; NPC, Niemann‐Pick protein](TRA-20-552-g001){#tra12670-fig-0001}

![Involvement of endocytic components in systemic metabolism during the fasting period. During fasting, blood glucose levels drop, leading to a reduction in insulin secretion by pancreatic β‐cells. Instead glucagon is secreted from pancreatic α‐cells, which mainly acts on hepatocytes and induces a signaling cascade that shifts the genomic program towards catabolism, producing glucose either by the breakdown of glycogen or de novo synthesis from pyruvate through gluconeogenesis. Hepatocytes will also produce energy by breaking down their triglyceride stores into non‐esterified fatty acids and burning them via β‐oxidation. Concomitantly, in the adipocytes, the drop in insulin will stop GLUT4 translocation, which will be removed from the plasma membrane through endocytosis and stored in GLUT4 storage vesicles, leading to the arrest of glucose uptake by the adipocyte. This is also accompanied by an activation of triglyceride lipolysis releasing glycerol and NEFA into the blood. Glycerol will be used by hepatocytes to generate pyruvate essential for gluconeogenesis, and NEFA will be burned via β‐oxidation. Examples of endocytic components that play a role in these metabolic processes are labeled in red. EE, early endosomes; ERC, endosomal recycling compartment; GSVs, GLUT4 storage vesicles; ISGs, insulin secretory vesicles; LYS, lysosome; TG, triglycerides; GR, glucagon receptor; IR, insulin receptor; NEFA, non‐esterified fatty acids](TRA-20-552-g002){#tra12670-fig-0002}

This review will highlight how different levels of endosomal regulation can be integrated into our understanding of metabolic homeostasis and discuss components of the endocytic system that regulate systemic glucose and lipid metabolism, based mainly on in vivo studies in mice and humans. We will not address amino acid metabolism and lysosomal nutrient sensing via mechanistic Target of Rapamycin, as this has been discussed extensively elsewhere.[18](#tra12670-bib-0018){ref-type="ref"}, [19](#tra12670-bib-0019){ref-type="ref"}, [20](#tra12670-bib-0020){ref-type="ref"} Instead, we will focus on the parts of the endosomal system that contribute to metabolic control and potentially participate in the development of insulin resistance, hyperglycemia and steatosis (lipid accumulation within liver and muscle), leading to type 2 diabetes.

2. REGULATION OF GLUCOSE AND LIPID METABOLISM THROUGH THE ENDOSOMAL SYSTEM {#tra12670-sec-0002}
==========================================================================

Glucose and lipid homeostasis are achieved by a balance between uptake of these nutrients, storage as glycogen or lipid droplets, and mobilization of those nutrient stores for energy production. The endosomal system participates in glucose and lipid uptake in the postprandial phase by regulating the expression of nutrient transporters and receptors on the cell surface. This can be achieved by enhanced recycling or reduced internalization. Upon surface appearance, nutrients can either bind to their receptors and be internalized, as exemplified by the LDL receptor (LDLR), or be actively transported into the cell, as in the case of fatty acids and glucose.

2.1. Regulation of glucose uptake and storage {#tra12670-sec-0003}
---------------------------------------------

Glucose uptake is induced upon food intake, when nutrients are enriched and blood glucose concentrations rise (Figure [1](#tra12670-fig-0001){ref-type="fig"}). This induces the secretion of insulin from the β‐cells of the pancreas, which leads to the uptake of glucose into peripheral tissues, such as adipose tissue and muscle, causing blood glucose levels to drop. Internalized glucose is used for the build up of glycogen in muscle or is metabolized through glycolysis to be incorporated into fatty acids for storage in fat. The uptake of glucose is mediated by the insulin‐dependent recruitment of the glucose transporter, GLUT4 from intracellular storage vesicles (GSVs).[21](#tra12670-bib-0021){ref-type="ref"}

2.2. Glucose transport through GLUT4 {#tra12670-sec-0004}
------------------------------------

The regulation of GLUT4 trafficking is one of the best examples of how endosomal transport participates in metabolic control. Many detailed mechanistic studies describing the intracellular transport steps of GLUT4 have been performed in cell lines, and these have been discussed in many elegant reviews.[21](#tra12670-bib-0021){ref-type="ref"}, [22](#tra12670-bib-0022){ref-type="ref"}, [23](#tra12670-bib-0023){ref-type="ref"}, [24](#tra12670-bib-0024){ref-type="ref"}, [25](#tra12670-bib-0025){ref-type="ref"} In this review, we will focus instead on in vivo studies, where components of the endosomal system have been shown to affect GLUT4 trafficking in tissues with immediate impact on systemic metabolism, and which are affected in metabolic disorders in humans.

As a transporter that cycles between intracellular compartments and the plasma membrane, GLUT4 traffics through all stages of the endosomal system, hence it is not surprising that many endosomal proteins have been shown to affect the behavior of GLUT4. Starting at the plasma membrane, dynamin 2 was shown already in the late 1990s to be required for GLUT4 internalization in primary rat adipocytes,[26](#tra12670-bib-0026){ref-type="ref"} which is consistent with its role in endocytic vesicle scission. Mutations in DNM2 have been linked to centronuclear myopathy (CNM), a diabetic late complication involving impaired actin‐dependent trafficking in human muscle cells.[9](#tra12670-bib-0009){ref-type="ref"} Interestingly, biopsies of patients with CNM reveal aberrant perinuclear accumulation of GLUT4, underscoring the importance of dynamin 2 in internalization and actin remodeling even in humans.[9](#tra12670-bib-0009){ref-type="ref"} In diabetes‐induced nephropathy, induction of actin‐dependent dynamin oligomerization has been shown to improve renal health in models of transient and chronic kidney diseases, which is relevant for diabetes‐induced renal dysfunction.[27](#tra12670-bib-0027){ref-type="ref"} Whether this is mediated through the spatiotemporal reorganization of cell surface molecules upon dynamin activation or alterations in signaling properties in diverse models of transient kidney diseases remains to be elucidated.

Upon internalization, GLUT4 traffics through the early endosomes, where the requirement for early endosomal Rabs, such as Rab4 and Rab5, has been shown in 3T3‐L1 adipocytes in vitro.[28](#tra12670-bib-0028){ref-type="ref"}, [29](#tra12670-bib-0029){ref-type="ref"}, [30](#tra12670-bib-0030){ref-type="ref"}, [31](#tra12670-bib-0031){ref-type="ref"}, [32](#tra12670-bib-0032){ref-type="ref"}, [33](#tra12670-bib-0033){ref-type="ref"} Here, Huang et al[32](#tra12670-bib-0032){ref-type="ref"} raised the interesting idea that insulin inhibits Rab5 activity and the interaction of dynein with microtubules, and that these effects may inhibit the rate of GLUT4 internalization, resulting in enhanced surface expression of GLUT4. Whether this mechanism affects the presence of GLUT4 at the cell surface in adipose tissue and muscle in mice in vivo needs to be determined. Whole‐body knockout mice for Rab4a and Rab4b display a reduction in circulating triglycerides and an increase in their total body fat mass, respectively, indicating a function of Rab4 in lipid metabolism (IMPC). The phenotype of Rab4b knockout mice could be in part due to the key role of Rab4b in adipose tissue T cells, as was recently demonstrated.[34](#tra12670-bib-0034){ref-type="ref"} After passing through early endosomes, GLUT4 traffics through the endosomal recycling compartment, involving Rab11. Although Rab11 has been shown to be required for proper GLUT4 trafficking in adipocytes in vitro,[35](#tra12670-bib-0035){ref-type="ref"} its function in metabolic regulation in vivo remains unclear. Whole‐body knockout mice indicate an essential role for Rab11a in development, whereas Rab11b knockout mice have no phenotype (IMPC). Only knockout mice of a Rab11 interactor, Rab11‐FIP3, exhibit decreased body fat accumulations (IMPC). However, how this connects to GLUT4 trafficking and glucose homeostasis still needs to be elucidated.

An interesting feature of the recycling endosomes is to sequester cargo into a specialized recycling compartment, which is utilized in many tissues to specifically initiate the delivery of these cargoes to the plasma membrane in response to stimuli. This feature is used in GLUT4 trafficking for targeting of GLUT4 to the cell surface in adipocytes and muscle cells. Interestingly, in addition to GLUT4, the delivery of aquaporins to the basal membrane in the kidney[36](#tra12670-bib-0036){ref-type="ref"} or the transport of bile acid transporters to the apical bile canaliculi in hepatocytes[37](#tra12670-bib-0037){ref-type="ref"} is mediated via a similar storage compartment, highlighting a common concept of cargo sequestration and recruitment in physiology.

GLUT4 is retained in a specialized intracellular compartment and is targeted to the plasma membrane via insulin‐regulated vesicular trafficking.[21](#tra12670-bib-0021){ref-type="ref"}, [23](#tra12670-bib-0023){ref-type="ref"} Insulin induces an inactivation of the Rab GTPase activating proteins (GAPs) necessary for GLUT4 translocation, namely TBC1D4/AS160 and TBC1D1. This is achieved by an AKT‐dependent phosphorylation of these Rab‐GAPs, leading to a loss of their inhibitory role on the downstream Rabs necessary for GLUT4 trafficking to the cell surface. The Rabs for GLUT4 include Rab8a, Rab13 and Rab14 in muscle cells[38](#tra12670-bib-0038){ref-type="ref"}, [39](#tra12670-bib-0039){ref-type="ref"}, [40](#tra12670-bib-0040){ref-type="ref"} and Rab10 and Rab35 in adipocytes.[41](#tra12670-bib-0041){ref-type="ref"}, [42](#tra12670-bib-0042){ref-type="ref"}, [43](#tra12670-bib-0043){ref-type="ref"} While many elegant studies have unraveled the function of these Rabs and other interacting proteins in cell lines (for detailed review see Reference [21](#tra12670-bib-0021){ref-type="ref"}), only Rab10\'s function has been elucidated in mice. Adipose‐specific knockout of Rab10 causes a 50% reduction in insulin‐stimulated glucose uptake and GLUT4 translocation to the plasma membrane in fat, leading to a near complete failure of insulin to suppress hepatic glucose production without significant inhibition of muscle glucose uptake.[44](#tra12670-bib-0044){ref-type="ref"} These data indicate that the amount of glucose uptake in adipocytes is a measure of whole‐body glucose homeostasis that affects liver insulin sensitivity. Interestingly, Rab10 has been shown to interact with Sec16a, which is important for the biogenesis of GLUT4 transport vesicles at the *trans* Golgi network (TGN), suggesting a cooperative action of GLUT4 vesicle recycling and accelerated biogenesis to maintain the elevated cell‐surface expression of GLUT4 under insulin stimulation.[45](#tra12670-bib-0045){ref-type="ref"} It will be interesting to see the role Rab8a and Rab13 play in muscle tissue in vivo and how interfering with their function affects GLUT4 trafficking and whole body glucose homeostasis.

The fusion of GLUT4 containing vesicles (GSVs) with the plasma membrane is an essential aspect in GLUT4 translocation upon insulin stimulation and has been extensively reviewed.[46](#tra12670-bib-0046){ref-type="ref"} This process has been shown to require Munc18c in 3T3‐L1 adipocytes.[47](#tra12670-bib-0047){ref-type="ref"} Interestingly, heterozygous Munc18c knockout mice show a decrease in GLUT4 translocation in skeletal muscle and alterations of glucose‐stimulated insulin secretion in pancreatic islets. This leads to severe glucose intolerance upon feeding a high fat diet, suggesting its importance not only for regulation of GLUT4 traffic but also other processes in β‐cells.[48](#tra12670-bib-0048){ref-type="ref"}

Altogether, these data support an essential function of the specialized recycling compartment in regulating GLUT4 distribution and glucose transport that is essential in whole body glucose homeostasis. In fact, it has been shown that defective GLUT4 translocation is a strong feature of insulin resistance and type 2 diabetes in humans.[12](#tra12670-bib-0012){ref-type="ref"}, [13](#tra12670-bib-0013){ref-type="ref"}, [14](#tra12670-bib-0014){ref-type="ref"} In addition, variants in the clathrin heavy chain CHC22 in humans are associated with altered GLUT4 trafficking and correlate with impaired GLUT4 translocation observed in type 2 diabetes.[15](#tra12670-bib-0015){ref-type="ref"} These data underscore the important contribution of the endosomal system in proper GLUT4 trafficking, where many components have been studied in cell lines. As GLUT4 traffics through many stages of the endosomal network throughout its cellular cycles, it is not surprising that many components affect GLUT4 behavior. However, it would be interesting to see whether these components are altered in diabetic conditions and how trafficking of GLUT4 might change in diabetes. Trafficking studies in isolated primary adipocytes from diabetic mice might give answers in this direction.

2.3. Glucose transport through GLUT1 and GLUT2 {#tra12670-sec-0005}
----------------------------------------------

Other glucose transporters, such as GLUT1 and GLUT2 are not insulin‐dependent. GLUT1 is expressed in all cell types and is responsible for steady‐state uptake of glucose. Interestingly, depletion of the retromer complex, which is involved in the retrieval of cargoes back to the TGN,[5](#tra12670-bib-0005){ref-type="ref"}, [6](#tra12670-bib-0006){ref-type="ref"}, [49](#tra12670-bib-0049){ref-type="ref"}, [50](#tra12670-bib-0050){ref-type="ref"} was shown to enhance degradation of GLUT1 and reduce cellular glucose uptake.[51](#tra12670-bib-0051){ref-type="ref"}, [52](#tra12670-bib-0052){ref-type="ref"}, [53](#tra12670-bib-0053){ref-type="ref"}, [54](#tra12670-bib-0054){ref-type="ref"} The retromer complex is composed of a VPS complex (Vps35, Vps29 and Vps26), which engages cargoes, and a sorting nexin‐Bin/amphiphysin/Rvs (SNX‐BAR) complex (SNX1, SNX2, SNX3, SNX5, SNX6 and SNX27), which bends the membrane (for review see References [6](#tra12670-bib-0006){ref-type="ref"}, [55](#tra12670-bib-0055){ref-type="ref"}). The whole‐body knockout mice of the core component of the retromer complex, Vps35, are embryonically lethal,[56](#tra12670-bib-0056){ref-type="ref"} but whole‐body heterozygous depletion is not associated with a specific phenotype (IMPC). Consistent with these observations, knockout of the cargo adapter proteins SNX3 and SNX27 are homozygous lethal or sub‐lethal (IMPC), suggesting that the retromer complex is essential for cellular homeostasis.

GLUT2 is expressed on β‐cells and in the liver. It has not been shown to be sequestered into storage vesicles or to be recruited upon stimulation. In the liver, GLUT2 is a bi‐directional transporter that internalizes and secretes glucose depending on its intracellular and extracellular concentrations.[57](#tra12670-bib-0057){ref-type="ref"} In the postprandial state, glucose is taken up into the liver and used mainly for glycogen production (Figure [1](#tra12670-fig-0001){ref-type="fig"}). This glycogen can then be used for maintaining blood glucose levels under starvation. The reduction of blood glucose concentrations induces the release of glucagon from the α‐cells of the pancreas, causing the breakdown of glycogen and induction of glucose production through gluconeogenesis in the liver, resulting in normalization of blood glucose concentrations (Figure [2](#tra12670-fig-0002){ref-type="fig"}).

In rodent β‐cells, GLUT2 is the principal glucose transporter, while in human β‐cells both GLUT1 and GLUT2 are involved in glucose transport.[58](#tra12670-bib-0058){ref-type="ref"}, [59](#tra12670-bib-0059){ref-type="ref"} Interestingly, *GLUT2*/*SLC2A2* variants confer type 2 diabetes risk, indicating that GLUT1 and GLUT2 function is not completely redundant.[58](#tra12670-bib-0058){ref-type="ref"} Importantly, extra‐ and intra‐cellular glucose concentrations equilibrate quickly in pancreatic islets, suggesting that glucose transport is not the rate‐limiting step in β‐cell glucose metabolism. Instead, β‐glucokinase (GCK/hexokinase 4) activity is crucial to keep glucose inside the cell and to initiate glycolysis.[60](#tra12670-bib-0060){ref-type="ref"} Glucose‐dependent mitochondrial ATP production in turn initiates insulin secretion by closing ATP‐dependent K^+^ channels and subsequent opening of voltage‐gated Ca^2+^ channels.[61](#tra12670-bib-0061){ref-type="ref"}

The trafficking of GLUT2 was found to be controlled by the Wiskott‐Aldrich syndrome protein and SCAR homolog (WASH) complex in mouse pancreatic β‐cells. Indeed, pancreas‐specific deletion of the WASH component WASHC1 causes intracellular accumulation of GLUT2 and decreased GLUT2 protein levels leading to impaired blood glucose clearance and reduced insulin secretion.[62](#tra12670-bib-0062){ref-type="ref"} Because the WASH complex, composed of WASHC1, WASHC2, WASHC3, WASHC4 and WASHC5, is an important player in the retrieval of cargoes from the endosomes (for review see Reference [6](#tra12670-bib-0006){ref-type="ref"}), it is likely that WASH complex depletion enhances protein degradation upon reduced protein retrieval. Whether the retrieval of cargo through the WASH complex is sensitive to extracellular metabolic cues remains to be determined. However, it is important to realize that glucose uptake via GLUT2 in β‐cells seems to be mainly observed in rodents, whereas humans internalize glucose also through GLUT1,[58](#tra12670-bib-0058){ref-type="ref"}, [59](#tra12670-bib-0059){ref-type="ref"} making the direct translation of these trafficking studies to the human situation difficult.

An important part of glucose uptake is the adequate release of insulin from β‐cells. This is mediated in a bi‐phasic mode, where pre‐docked and ready to fuse insulin secretory granules are secreted in the first phase of glucose‐induced insulin secretion happening in seconds. The second phase insulin secretion requires re‐internalization of the machinery necessary for insulin granule production and trafficking, where endocytosis plays an important role. Here, rearrangements of the actin cytoskeleton are needed for proper insulin secretion. Components of the endosomal machinery, such as Cdc42 have been implicated in this process. Knockdown of Cdc42 in isolated mouse islets results in the selective loss of the second phase insulin release, potentially causing less insulin secretion, which could lead to an increase in blood glucose levels.[63](#tra12670-bib-0063){ref-type="ref"} In fact, islets from donors with type 2 diabetes have profound defects in glucose‐stimulated Cdc42‐PAK1 activation and insulin secretion, which might contribute to the failure of the β‐cells to secrete insulin in diabetes.[64](#tra12670-bib-0064){ref-type="ref"} Here, it is suggested that glucose induces the translocation of Cdc42 to the plasma membrane, which activates the Cdc42‐PAK1‐RAC1 pathway, leading to cytoskeletal rearrangements and enhanced fusion of insulin granules with the plasma membrane.[64](#tra12670-bib-0064){ref-type="ref"} In addition, β‐cell‐specific inducible DMN2 knockout mice show a requirement for dynamin 2 in glucose tolerance and proper glucose‐induced second phase insulin secretion in mice.[65](#tra12670-bib-0065){ref-type="ref"} Interestingly, the decrease in insulin secretion is due to a disorganization and enhancement of the actin cytoskeletal network,[65](#tra12670-bib-0065){ref-type="ref"} which underscores a function for dynamin 2 in plasma membrane actin remodeling that is not directly related to its role in vesicle scission.

2.4. Regulation of LDL‐C uptake {#tra12670-sec-0006}
-------------------------------

The uptake of LDL‐C by the liver is crucial for lipid homeostasis. In hepatocytes, internalized cholesterol esters in LDL are hydrolyzed to free cholesterol in late endosomes/lysosomes. Subsequently, through the Nieman‐Pick Type‐C proteins, cholesterol is further transported to other cellular compartments and either used as a component of intracellular membranes[66](#tra12670-bib-0066){ref-type="ref"} or metabolized into bile acids and released into the bile canaliculi.[67](#tra12670-bib-0067){ref-type="ref"} Through this, the liver can actively reduce whole‐body cholesterol levels via LDL‐C endocytosis. A common feature of type 2 diabetes is hypercholesterolemia and fatty liver disease, which can develop through reduced uptake of LDL‐C or enhanced secretion of very low density lipoprotein from the liver. Thus, by altering LDLR trafficking, endocytosis participates actively in LDL‐C clearance. While it was thought that the recycling of receptors, including the LDLR, is a relatively passive process following bulk flow,[68](#tra12670-bib-0068){ref-type="ref"} recent evidence has clearly illustrated that these trafficking processes are spatially and temporally regulated by a large number of multi‐protein complexes.[5](#tra12670-bib-0005){ref-type="ref"}, [6](#tra12670-bib-0006){ref-type="ref"}, [49](#tra12670-bib-0049){ref-type="ref"}, [50](#tra12670-bib-0050){ref-type="ref"}, [69](#tra12670-bib-0069){ref-type="ref"}

Underlining the pivotal role of endocytosis on LDLR trafficking, we previously demonstrated that the depletion of Rab5 in mouse liver in vivo leads to a decrease in LDL‐C uptake due to failure of LDLR internalization.[7](#tra12670-bib-0007){ref-type="ref"}, [8](#tra12670-bib-0008){ref-type="ref"} In this study, we took advantage of a hepatocyte‐specific delivery system, where siRNAs encapsulated into lipid nanoparticles are exclusively taken up by the liver,[70](#tra12670-bib-0070){ref-type="ref"} inducing a tissue‐specific knockdown of Rab5 in adult mice. The defects in LDL‐C uptake were sufficient to induce hypercholesterolemia and hyperlipidemia in the blood of these animals. Remarkably, depletion of Rab5 was sufficient to abolish the biogenesis of early endosomes causing a reduction of the entire degradative pathway,[7](#tra12670-bib-0007){ref-type="ref"} making the dissection of the metabolic phenotypes and underlying molecular mechanisms challenging.

2.5. The role of the retriever‐CCC‐WASH complex in controlling lipid homeostasis {#tra12670-sec-0007}
--------------------------------------------------------------------------------

The retriever‐CCC‐WASH complex participates in cargo sorting[6](#tra12670-bib-0006){ref-type="ref"} downstream of Rab5 by recruiting F‐actin onto endosomes via the WASH complex, as described above, recognizing cargoes via the CCC complex (COMMD, CCDC22 and CCDC93) and sorting them via the retriever complex (DSCR3, C16orf62 and Vps29). Interestingly, this large complex was also found to be implicated in lipid homeostasis. Indeed, patients with X‐linked intellectual disability involving a CCDC22 p.T17A or CCDC22 p.Y557C mutation were found to have an increase in total plasma cholesterol and LDL‐C levels.[71](#tra12670-bib-0071){ref-type="ref"} Moreover, liver‐specific COMMD1 knockout mice show elevated plasma LDL‐C and exhibit a mislocalization of LDLR associated with decreased LDL‐C uptake in the liver.[71](#tra12670-bib-0071){ref-type="ref"} COMMD1 is the founding member of a family of 10 proteins expressing the Copper Metabolism MURR1 Domain (COMMD) at their carboxy terminus. All are able to engage the CCC complex to fulfill their discrete functions, including cell proliferation, copper homeostasis and regulation of NF‐κB and sodium channels activities.[72](#tra12670-bib-0072){ref-type="ref"}, [73](#tra12670-bib-0073){ref-type="ref"}, [74](#tra12670-bib-0074){ref-type="ref"}, [75](#tra12670-bib-0075){ref-type="ref"} Strikingly, the increase in plasma cholesterol in liver‐specific COMMD1, COMMD6 or COMMD9 knockout mice causes an exacerbation of atherosclerosis, highlighting a collective function of COMMDs and CCC components in modulating plasma lipid levels in humans.[10](#tra12670-bib-0010){ref-type="ref"}

Considering the large number of nutrient transporters and receptors trafficking through the endosomal system, which all need to escape degradation, it seems likely that additional functions of the CCC‐WASH‐retriever complex and the retromer complex will be discovered. It will be interesting to see how cargo specificity in the retrieving pathway is achieved and how this is physiologically regulated. Recently, an elegant study has suggested that the adaptor protein PID1, which regulates whole body glucose homeostasis,[76](#tra12670-bib-0076){ref-type="ref"} is an insulin‐dependent molecular switch that regulates the cellular distribution of another cholesterol transporter, LRP1 (low density lipoprotein particle related protein 1), and functions in the postprandial state by controlling SNX17 binding to LRP1.[77](#tra12670-bib-0077){ref-type="ref"} Interestingly, the CCC complex is also required for LRP1 trafficking to the plasma membrane, suggesting that this complex could mediate the insulin‐dependent regulation of LRP1 trafficking via PID1.[10](#tra12670-bib-0010){ref-type="ref"}, [71](#tra12670-bib-0071){ref-type="ref"} Whether this is regulated through a direct interaction with the CCC‐WASH‐retriever complex with PID1 still needs to be determined.

In addition to LDLR trafficking, endocytosis participates in the regulation of cholesterol flux within cells, which requires the function of Niemann‐Pick type C (NPC) proteins. Indeed, mutations of Vps53 prevent the proper sorting of NPC2 to lysosomes, causing cholesterol accumulation.[78](#tra12670-bib-0078){ref-type="ref"} Vps53 is a common component of two complexes, the endosome‐associated recycling protein (EARP) and the Golgi‐associated retrograde protein (GARP), which are implicated in the tethering of cargo‐containing carriers sorted from the endosomes to direct them either to the recycling compartments or the TGN, respectively (for review see Reference [79](#tra12670-bib-0079){ref-type="ref"}). Consistent with this finding, mutation of the specific component of the GARP complex, Vps54, in human amyotrophic lateral sclerosis (ALS) patients and in wobbler mice was found to be associated with a dysregulation of energy metabolism.[11](#tra12670-bib-0011){ref-type="ref"}, [80](#tra12670-bib-0080){ref-type="ref"}, [81](#tra12670-bib-0081){ref-type="ref"} In wobbler mice, these energy metabolism defects were linked to a disturbance of cholesterol homeostasis,[78](#tra12670-bib-0078){ref-type="ref"} suggesting that the GARP complex may be involved in the regulation of cholesterol flux. However, this needs to be confirmed, because EARP and GARP complexes share one‐quarter of their components, such that affecting one complex may alter the other.

Altogether, these results show that the retrieval of cargoes from endosomes has important implications for lipid and glucose metabolism. This could be a consequence of cargo recycling to the plasma membrane that requires this sorting step. Whether this retrieval is controlled by extracellular stimuli that initiate the recycling of nutrient receptors to the cell surface remains to be seen, but it would provide an interesting mechanism to explain how metabolic cues and conditions could influence cargo retrieval.

3. METABOLIC SIGNAL PROCESSING THROUGH THE ENDOSOMAL SYSTEM {#tra12670-sec-0008}
===========================================================

3.1. Regulation of insulin and glucagon receptor trafficking {#tra12670-sec-0009}
------------------------------------------------------------

The regulation of the fasting/feeding transition is mediated by the action of insulin, glucagon and glucocorticoids. While the latter functions mainly through its nuclear receptor,[82](#tra12670-bib-0082){ref-type="ref"} insulin and glucagon signaling is mediated through their plasma membrane receptors. Extensive studies have investigated the role of the endosomal system on insulin receptor (IR) signaling and trafficking in cell lines.[83](#tra12670-bib-0083){ref-type="ref"} IR is internalized by clathrin‐dependent pathways[84](#tra12670-bib-0084){ref-type="ref"}, [85](#tra12670-bib-0085){ref-type="ref"} but also through caveolin‐mediated uptake,[86](#tra12670-bib-0086){ref-type="ref"}, [87](#tra12670-bib-0087){ref-type="ref"} suggesting that both processes exist and the receptor might utilize the different endocytic entry routes depending on the IR isoform, cell types and ligands. Nevertheless, the IR has been shown to localize to caveolae in adipocytes and myotubes,[86](#tra12670-bib-0086){ref-type="ref"}, [88](#tra12670-bib-0088){ref-type="ref"} and this localization seems to be essential for proper insulin signaling, which was found to require caveolin1 in adipocytes and caveolin3 in muscle cells.[88](#tra12670-bib-0088){ref-type="ref"}, [89](#tra12670-bib-0089){ref-type="ref"}, [90](#tra12670-bib-0090){ref-type="ref"} Indeed, the depletion of CAV1 or CAV3 in mice leads to insulin resistance in adipose tissue and muscle, respectively.[91](#tra12670-bib-0091){ref-type="ref"}, [92](#tra12670-bib-0092){ref-type="ref"} Importantly, the failure in insulin sensing by adipocytes results in a reduction in GLUT4 translocation (see above) and consequently reduced glucose storage into triglycerides, which could explain the lean phenotype and the resistance to diet‐induced obesity in caveolin1 knockout mice.[93](#tra12670-bib-0093){ref-type="ref"}

Besides these studies in caveolin knockout mice, there are very few examples that investigate whether components of the endosomal system alter IR signaling and insulin sensitivity in vivo. The reason for this could be that the active internalized IR, which continues to signal on early endosomes,[94](#tra12670-bib-0094){ref-type="ref"} is more important for its mitogenic than its metabolic function.[95](#tra12670-bib-0095){ref-type="ref"} However, recent data have identified SORLA (sorting‐related receptor with type A repeats, encoded by *SORL1*) as directing the IR back to the plasma membrane and enhancing IR signaling, thereby contributing to glucose intolerance and obesity.[96](#tra12670-bib-0096){ref-type="ref"} This highlights the importance of the balance between IR recycling and degradation for metabolic control.

The glucagon receptor is a prototypical G protein‐coupled receptor, for which prolonged agonist stimulation attenuates signaling (homologous desensitization). However, internalization of the desensitized receptors and their sequestration into intracellular vesicles is a primary mechanism of signal attenuation and is essential for receptor resensitization (for review see Reference [97](#tra12670-bib-0097){ref-type="ref"}). Internalization of the glucagon receptor is mediated by clathrin‐dependent endocytosis in hepatocytes,[98](#tra12670-bib-0098){ref-type="ref"} as well as through caveolin.[99](#tra12670-bib-0099){ref-type="ref"} This dual mode of internalization may differ depending on the cell types and may have important consequences for signaling outcomes. However, it remains unclear whether endocytosis participates in glucagon signaling independently of its role in receptor distribution.

3.2. Signal interpretation through the endosomal system {#tra12670-sec-0010}
-------------------------------------------------------

While signaling receptor trafficking is important for signal transduction and downregulation, specific components of the endosomal system could play important roles in signal interpretation by interacting with downstream signaling receptor targets. Indeed, the surface of endosomes functions as a platform for signaling domains[100](#tra12670-bib-0100){ref-type="ref"} that control the spatiotemporal distribution of signaling molecules within the cell.[101](#tra12670-bib-0101){ref-type="ref"} Interestingly, the Rab5 effector APPL (adaptor protein containing PH domain, PTB domain and Leucine zipper motif) has been shown to interact with AKT2 on endosomes,[100](#tra12670-bib-0100){ref-type="ref"}, [102](#tra12670-bib-0102){ref-type="ref"} suggesting a potential metabolic function. In fact, APPL1 was reported to interact with adiponectin, an adipocyte hormone that is important for glucose sensitivity and fatty acid oxidation.[103](#tra12670-bib-0103){ref-type="ref"} APPL1 has been shown to be necessary for adiponectin functions, such as lipid oxidation, glucose uptake and GLUT4 translocation in L6‐myotubes.[104](#tra12670-bib-0104){ref-type="ref"} There, adiponectin stimulates the interaction between APPL1 and Rab5, leading to increased GLUT4 translocation. It would be interesting to see whether insulin influences this interaction in muscle.

Besides its function in mediating glucose uptake in fat and muscle, insulin also acts on the liver during feeding by reducing the expression of gluconeogenic genes, such as *Glucose‐6‐phosphatase* (*G6Pase*), which is rate limiting for glucose output.[105](#tra12670-bib-0105){ref-type="ref"} This is achieved by AKT‐mediated phosphorylation of Forkhead box‐O1 (FOXO1), a main transcription factor for gluconeogenesis, resulting in FOXO1 inactivation.[106](#tra12670-bib-0106){ref-type="ref"} As APPL1 has been shown to interact with the metabolically active isoform AKT2,[100](#tra12670-bib-0100){ref-type="ref"}, [102](#tra12670-bib-0102){ref-type="ref"} it is not surprising that liver‐specific overexpression of APPL1 by adenovirus results in increased hepatic insulin sensitivity and enhanced insulin‐induced suppression of the gluconeogenic program,[107](#tra12670-bib-0107){ref-type="ref"} while its knockdown has the opposite effect. The improvement of insulin sensitivity is achieved by binding of APPL1 to AKT2, thereby preventing the interaction of AKT2 with its inhibitor Tribble3 (TRB3),[108](#tra12670-bib-0108){ref-type="ref"} thus promoting AKT translocation to the plasma membrane and inducing enhanced AKT signaling. Interestingly, conditional deletion of APPL2 in skeletal muscle exhibits the opposite phenotype. Here, insulin‐induced plasma membrane recruitment of GLUT4 and glucose uptake are impaired by APPL2 overexpression but are enhanced upon knockdown, leading to improved glucose tolerance.[109](#tra12670-bib-0109){ref-type="ref"} This is achieved by a direct interaction of APPL2 with the Rab‐GTPase activating protein TBC1D1, which is necessary for GLUT4 translocation. Why APPL1 and APPL2 have these opposite effects and interaction partners, and how they are physiologically regulated upon glucose challenge, remains to be elucidated. The pathophysiological significance of APPL1/2 for glucose homeostasis, however, is supported by observations in diabetic patients and patients with NAFLD, where loss‐of‐function mutations in APPL1 and genetic variation in APPL1/APPL2 loci are linked to familial forms of diabetes[16](#tra12670-bib-0016){ref-type="ref"} and hepatic steatosis,[17](#tra12670-bib-0017){ref-type="ref"} respectively.

As APPL1 is a well‐established Rab5 effector, one would assume that interfering with Rab5 would mimic the APPL1 phenotype in relation to insulin sensitivity and glucose production. Surprisingly, depletion of Rab5 in the liver in vivo had no effect on insulin signaling and insulin‐induced AKT activation.[8](#tra12670-bib-0008){ref-type="ref"} Nevertheless, we still observed a strong reduction in gluconeogenic genes causing an almost complete block of glucose output, thus inducing hypoglycemia. Usually, reduced blood glucose levels induce glucagon signaling, causing upregulation of gluconeogenesis through cyclic‐AMP‐mediated activation of protein kinase A (PKA). This results in phosphorylation and activation of the transcription factor cAMP responsive binding protein (CREB) and the expression of FOXO1, which function together to drive the gluconeogenic program.[105](#tra12670-bib-0105){ref-type="ref"}, [110](#tra12670-bib-0110){ref-type="ref"}, [111](#tra12670-bib-0111){ref-type="ref"} Despite activated PKA and enhanced cAMP production under Rab5 knockdown, the expression of FOXO1 and the CREB downstream target PPARγ coactivator protein 1α (PGC1α) is strongly diminished, abolishing *G6Pase* gene expression.[8](#tra12670-bib-0008){ref-type="ref"} However, how Rab5 affects CREB and FOXO1 function still needs to be determined. One possibility is that the endosomal membranes could serve as platforms for factors such as FOXO1 to interact with their signaling kinases, which regulate their activity. Upon loss of the endosomal membranes due to Rab5 knockdown,[7](#tra12670-bib-0007){ref-type="ref"} those platforms are not available anymore, which actually leads to the observed redistribution of FOXO1 and CREB in the liver.[8](#tra12670-bib-0008){ref-type="ref"} Importantly, *G6Pase* is highly upregulated in type 2 diabetic livers, which contributes to enhanced glucose production and hyperglycemia. Therefore, it is intriguing to note that depletion of *Rab5* in diabetic *db*/*db* mice can rescue their elevated blood glucose levels by downregulating *G6Pase* expression,[8](#tra12670-bib-0008){ref-type="ref"} highlighting a potential therapeutic application for metabolic diseases.

Further support for a function of early endosomes in metabolic signaling comes from studies interfering with the class III PI3 kinase, Vps34. Although Vps34 is not directly downstream of insulin signaling, knockouts of Vps34 and Vps15 in mice show enhanced insulin sensitivity and glucose tolerance, with reduced hepatic glucose production.[112](#tra12670-bib-0112){ref-type="ref"}, [113](#tra12670-bib-0113){ref-type="ref"} The effect on glucose production was found to be due to a strong reduction of gluconeogenic genes in hepatocytes, caused by an alteration in insulin‐induced AKT activation.[113](#tra12670-bib-0113){ref-type="ref"} However, none of these approaches seem to reduce the number of endosomes, suggesting an alternative mechanism compared to Rab5 knockdown. Altogether, these data highlight unexpected functions of endocytic components on metabolic gene regulation, where the underlying mechanisms still need to be further explored.

Glucose‐stimulated insulin secretion has been shown to depend on EphrinA (EFNA)/EphrinA‐receptor (EPHA) signaling[114](#tra12670-bib-0114){ref-type="ref"} and single‐cell transcriptomics of human pancreatic islets revealed that the EPH‐receptor and EFN‐ligand family was significantly enriched.[115](#tra12670-bib-0115){ref-type="ref"} In islets of a β‐cell‐specific, inducible intraflagellar Transport 88 *(Ift88)*‐knockout mouse model, EphA3 is hyperphosphorylated, blocking glucose‐stimulated insulin secretion, resulting in reduced glucose tolerance.[116](#tra12670-bib-0116){ref-type="ref"} In these cells, pEphA is not efficiently internalized and trafficked to the perinuclear region where the main protein tyrosine phosphatase is located that suppresses spontaneous, ligand‐independent activation. This represents one example for metabolic defects related to impaired endosomal signal processing.

There are many more metabolic signaling receptors that are important for glucose and lipid homeostasis, such as the GIP receptor (GIPR), GLP1 receptor, leptin receptor, FGF21 co‐receptors FGFR1 and β‐Klotho, where we have yet to determine how they are trafficked through the endosomal system and whether the transport is important for receptor function. These receptors are expressed in many different tissues, such as adipocytes, which could be used to study their trafficking and signaling. In fact, activation of GIPR by ligand binding in 3T3‐L1 adipocytes has been shown to induce a slow recycling of GIPR without changing internalization, resulting in receptor desensitization.[117](#tra12670-bib-0117){ref-type="ref"} Genome‐wide association studies (GWAS) have shown that mutations of this receptor are associated with obesity, cardiovascular disease and an increased risk for bone fractures in humans.[118](#tra12670-bib-0118){ref-type="ref"}, [119](#tra12670-bib-0119){ref-type="ref"}, [120](#tra12670-bib-0120){ref-type="ref"} These mutations cause enhanced receptor desensitization and downregulation,[117](#tra12670-bib-0117){ref-type="ref"} underscoring how subtle changes in trafficking of GIPR impact human physiology. It will be interesting to see how these mutations affect the behavior of GIPR in vivo in mice and whether the induced metabolic alterations can explain the human correlations with obesity in these GWAS study.

4. THE ROLE OF ENDOSOMAL DEGRADATION IN METABOLIC CONTROL {#tra12670-sec-0011}
=========================================================

Degradation is an essential process in the regulation of energy homeostasis. This includes controlling the cellular amount of nutrient receptors or transporters, which are necessary for cargo entry. The degradation of activated signaling receptors is pivotal for signal downregulation to avoid prolonged signaling. In addition, the release of energy stored as macromolecules may require degradation processes through the lysosome.

4.1. Degradation of nutrient transporters/receptors {#tra12670-sec-0012}
---------------------------------------------------

All cargo that has not been sorted in early endosomes for recycling through multiple recycling and retrieval complexes[6](#tra12670-bib-0006){ref-type="ref"} will be sent to lysosomes for degradation. Therefore, these retrieval complexes play essential roles in regulating the expression of nutrient transporters and receptors at the cell surface. We have already reviewed some of those in the section on nutrient uptake, where retromer was important for GLUT1 recycling,[53](#tra12670-bib-0053){ref-type="ref"}, [54](#tra12670-bib-0054){ref-type="ref"} WASH complex for GLUT2 and LDLR[62](#tra12670-bib-0062){ref-type="ref"}, [71](#tra12670-bib-0071){ref-type="ref"} and the CCC complex for LDLR and LRP1.[10](#tra12670-bib-0010){ref-type="ref"} With so many nutrient transporters and receptors trafficking through the endosomal pathway, it will be interesting to see how their recycling and degradation are regulated, and whether the fate of these cargoes changes in metabolic diseases. One could imagine that enhanced degradation of particular nutrient receptors, possibly through malfunction of the retrieval proteins, could participate in the metabolic imbalance observed in diabetes and obesity.

4.2. Degradation of signaling receptors {#tra12670-sec-0013}
---------------------------------------

As discussed above, the signaling cascades that emerge following receptor‐ligand binding regulate several metabolic functions. Importantly, these signals need to be transient to induce a proper cellular response and avoid continuous activation of cells. The signaling peaks are mechanistically achieved by desensitization of the signaling receptors mainly via their lysosomal degradation. Therefore, perturbing signaling receptor degradation may have an important metabolic impact. Consistent with this possibility, conditional knockout of EPN1 and EPN2 in lymphatic endothelial cells prevent VEGF‐C‐induced vascular endothelial growth factor receptor 3 (VEGFR3) from endocytosis and degradation.[121](#tra12670-bib-0121){ref-type="ref"} VEGFR3 is essential for lymphatic vessel growth and lymphangiogenesis, and was found to drop during diabetes.[122](#tra12670-bib-0122){ref-type="ref"} Interestingly, the loss of lymphatic‐specific epsins alleviates insufficient lymphangiogenesis in diabetic mice, indicating a novel approach to treating diabetic complications.[122](#tra12670-bib-0122){ref-type="ref"}

Signaling receptors (mainly receptor tyrosine kinases) subject to degradation are marked by ubiquitination on lysine‐63 and are recognized by the evolutionarily conserved endosomal sorting complexes required for transport (ESCRT) machinery, which drives membrane deformation and vesicle scission to generate cargo‐enriched intraluminal vesicles.[123](#tra12670-bib-0123){ref-type="ref"}, [124](#tra12670-bib-0124){ref-type="ref"} In theory, the ESCRT machinery should play an essential role in the degradation of metabolically active signaling receptors. Not many studies have elucidated their function in metabolic homeostasis, however, probably also because some components of this machinery are essential for embryonic development, leading to embryonic lethality in whole‐body knockout mice (eg, TSG101, CHMP3, CHMP6, CHMP7) (IMPC). However, one study has highlighted how activation of the ESCRT machinery seems to protect against NAFLD and non‐alcoholic‐steatohepatitis development in mice and monkeys, by targeting toll‐like receptor 4 (TLR4) for degradation.[125](#tra12670-bib-0125){ref-type="ref"} This suggests that interfering with ESCRT complexes in mice in vivo will reveal novel roles for the ESCRT machinery in glucose and lipid metabolism.

4.3. Degradation of macromolecules {#tra12670-sec-0014}
----------------------------------

To keep whole‐body nutrient supplies constant during periods of fasting and feeding, energy stores in the form of fat and glycogen are built up in postprandial periods and mobilized under starvation. Although many endocytic processes are connected to nutrient uptake and storage (see above), the endocytic machinery is also useful for degrading macromolecular components. This includes processes related to lipid droplet and glycogen degradation. In relation to the endocytic system, Rab7 and Vps34, components that are shared between the endosomal and autophagic machinery, have been shown to be required for lipid droplet degradation via autophagy under nutrient starvation.[126](#tra12670-bib-0126){ref-type="ref"}, [127](#tra12670-bib-0127){ref-type="ref"} Interestingly, knockdown of Vps34 in mouse liver causes hepatomegaly and liver steatosis, underscoring its physiological relevance.[127](#tra12670-bib-0127){ref-type="ref"} However, the role of Rab7 in lipophagy has only been investigated in vitro, and further studies in vivo are still required. Interestingly, caveolin1 has also been implicated in liver steatosis and lipid transport, underscoring the diverse function of caveolae in metabolic control.[128](#tra12670-bib-0128){ref-type="ref"}

Glycogen is another storage macromolecule that is pivotal to maintain blood glucose concentrations (see above). Strikingly, we previously found that depletion of Rab5 in mouse liver leads to a dramatic accumulation of intrahepatocellular glycogen contents.[7](#tra12670-bib-0007){ref-type="ref"}, [8](#tra12670-bib-0008){ref-type="ref"} How the depletion of Rab5 could perturb glycogen breakdown is puzzling. One explanation is that the strong reduction in *G6Pase* expression, which is not only the rate‐limiting gene in gluconeogenesis but also in glycogenolysis, could cause accumulation of glycogen. Alternatively, the endo‐lysosomal system, which is abolished in the Rab5 knockdown, could be involved in glycogenolysis. Supporting this possibility, Pompe disease, a lysosomal storage disorder also known as glycogen storage disease type II, is caused by a mutation in the gene encoding the acid α‐glucosidase, which localizes to the lysosome to hydrolyze glycogen to glucose.[129](#tra12670-bib-0129){ref-type="ref"} Cytosolic glycogen seems to be targeted to lysosomes in the process of autophagy to achieve its breakdown.[130](#tra12670-bib-0130){ref-type="ref"}

Altogether, lysosomal degradation is essential in metabolic homeostasis, which has already been well recognized. The components of the endosomal system that initiate the sorting of cargoes for degradation have not been studied intensively in metabolic control. These components are decision drivers that could alter metabolic outcomes by changing the fate of nutrient transporters and metabolic signaling receptors towards degradation or recycling. It would be interesting to see whether metabolic cues influence their expression. In fact, promotor analysis of over 2000 new knockout mouse strains revealed an unknown link between the ESCRT‐III protein CHMP3 and metabolism. CHMP3 was among those candidates, and its promoter contains common regulatory elements functioning as transcription factor binding sites, which are co‐regulated upon metabolic alterations.[131](#tra12670-bib-0131){ref-type="ref"} This suggests a differential expression of at least CHMP3 in metabolic diseases. Whether this has functional consequences needs to be elucidated.

5. CONCLUSIONS AND OUTLOOK {#tra12670-sec-0015}
==========================

In the present review, we have highlighted how endosomal trafficking integrates into metabolic homeostasis and focused on components of the endocytic system with existing mechanistic implications. Besides those, there are still a large number of endocytic factors that influence metabolism but for which we lack an understanding of how and why. This is especially true in invertebrate model organisms, where several genome‐wide screens have been performed to identify genes implicated in either glucose or lipid metabolism. Strikingly, more than 30 endocytic components located all along the different endocytic pathways were found to impact glucose or lipid metabolism in *Caenorhabditis elegans*, *Drosophila melanogaster* or *Danio rerio* [132](#tra12670-bib-0132){ref-type="ref"}, [133](#tra12670-bib-0133){ref-type="ref"}, [134](#tra12670-bib-0134){ref-type="ref"}, [135](#tra12670-bib-0135){ref-type="ref"}, [136](#tra12670-bib-0136){ref-type="ref"}, [137](#tra12670-bib-0137){ref-type="ref"}, [138](#tra12670-bib-0138){ref-type="ref"}, [139](#tra12670-bib-0139){ref-type="ref"}, [140](#tra12670-bib-0140){ref-type="ref"}, [141](#tra12670-bib-0141){ref-type="ref"}, [142](#tra12670-bib-0142){ref-type="ref"}, [143](#tra12670-bib-0143){ref-type="ref"}, [144](#tra12670-bib-0144){ref-type="ref"} (see Table [1](#tra12670-tbl-0001){ref-type="table"}). Unfortunately, as these screens cannot reveal the mechanisms leading to changes in fat mass, glucose storage or catabolism, the metabolic functions of the identified genes remain unclear. Similarly, numerous other components have been found to play a role in mammalian metabolism, but the mechanisms of action are still not well defined[145](#tra12670-bib-0145){ref-type="ref"}, [146](#tra12670-bib-0146){ref-type="ref"}, [147](#tra12670-bib-0147){ref-type="ref"}, [148](#tra12670-bib-0148){ref-type="ref"}, [149](#tra12670-bib-0149){ref-type="ref"}, [150](#tra12670-bib-0150){ref-type="ref"}, [151](#tra12670-bib-0151){ref-type="ref"}, [152](#tra12670-bib-0152){ref-type="ref"}, [153](#tra12670-bib-0153){ref-type="ref"}, [154](#tra12670-bib-0154){ref-type="ref"}, [155](#tra12670-bib-0155){ref-type="ref"}, [156](#tra12670-bib-0156){ref-type="ref"}, [157](#tra12670-bib-0157){ref-type="ref"} (see Table [1](#tra12670-tbl-0001){ref-type="table"}). Thus, despite the large number of endosomal proteins that are now known to participate in metabolic regulation, there are still many for which a metabolic function is implied but not really mechanistically demonstrated. Why is that and what can we do better?

###### 

Involvement of endosomal components in metabolism

  Gene (complex)                Organism                                                                     Regulation                                                                                Metabolic/endocytic effect                                                                                                                                                                                                                                 Reference
  ----------------------------- ---------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------
  *Clathrin*                    *Caenorhabditis elegans*                                                     RNAi                                                                                      Increase glucose metabolism                                                                                                                                                                                                                                Lee et al[132](#tra12670-bib-0132){ref-type="ref"}
                                Human                                                                        Functional study and tissue specific o/e                                                  Clathrin heavy chain isoform CHC22 regulate GLUT4 compartment                                                                                                                                                                                              Vassilopoulos et al[15](#tra12670-bib-0015){ref-type="ref"}
  *AP‐2*                        *C. elegans*                                                                 RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Webster et al[134](#tra12670-bib-0134){ref-type="ref"}
                                *C. elegans*                                                                 RNAi                                                                                      Increase glucose metabolism                                                                                                                                                                                                                                Lee et al[132](#tra12670-bib-0132){ref-type="ref"}
  *Dab2*                        *Drosophila melanogaster*                                                    RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Pospisilik et al[135](#tra12670-bib-0135){ref-type="ref"}
                                Mice                                                                         KO                                                                                        Defect in adipogenesis. Reduction of fat mass                                                                                                                                                                                                              Tao et al[145](#tra12670-bib-0145){ref-type="ref"}
  *Epsin*                       *C. elegans*                                                                 RNAi                                                                                      Reduction of whole body fat content. Abnormal lipid metabolism                                                                                                                                                                                             Ashrafi et al[136](#tra12670-bib-0136){ref-type="ref"}
                                Mice                                                                         LEC‐iDKO                                                                                  Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes                                                                                                                                                           Wu et al[122](#tra12670-bib-0122){ref-type="ref"}
  *Dynamin*                     Primary rat adipocytes                                                       o/e of wt and GTPase def. dynamin2                                                        Dynamin 2 is necessary for GLUT4 internalization                                                                                                                                                                                                           Al‐Hasani et al[26](#tra12670-bib-0026){ref-type="ref"}
                                Human muscle cells                                                           o/e of mutant dynamin 2                                                                   Dynamin 2 mutations disrupted the formation of new actin filaments as well as the stimulus‐induced translocation of GLUT4 to the plasma membrane                                                                                                           González‐Jamett et al[9](#tra12670-bib-0009){ref-type="ref"}
                                Mice                                                                         Small molecule, dynamin 2 activator                                                       Pharmacological targeting of actin‐dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models                                                                                                                           Schiffer et al[27](#tra12670-bib-0027){ref-type="ref"}
                                Mice                                                                         Dynamin 2 deletion in β cells                                                             Dynamin 2 important for second phase insulin secretion                                                                                                                                                                                                     Fan et al[65](#tra12670-bib-0065){ref-type="ref"}
  *HSC70*                       *D. melanogaster*                                                            RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Pospisilik et al[135](#tra12670-bib-0135){ref-type="ref"}
                                STZ‐induced diabetic rats                                                    Expression                                                                                Abundance of Hsc70 increased by insulin. Downregulation of Hsc70 in diabetic myocardium was secondary to insulin deficiency                                                                                                                                Chen et al[146](#tra12670-bib-0146){ref-type="ref"}
  *Caveolin*                    *C. elegans*                                                                 Null mutant                                                                               Reduction of whole body fat content                                                                                                                                                                                                                        Han et al[137](#tra12670-bib-0137){ref-type="ref"}
                                Mice                                                                         Caveolin 1 KO                                                                             Caveolin‐1‐deficient mice are lean, resistant to diet‐induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. Caveolin‐1‐deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue   Razani et al[93](#tra12670-bib-0093){ref-type="ref"}; Cohen et al[91](#tra12670-bib-0091){ref-type="ref"}
                                Mouse liver                                                                                                                                                            Caveolin‐1 function in glucose and lipid metabolism in the liver                                                                                                                                                                                           Fernandez‐Rojo and Ramm[128](#tra12670-bib-0128){ref-type="ref"}
                                Mouse adipocytes                                                             Localization                                                                              IR is highly enriched in caveolae structures by EM                                                                                                                                                                                                         Gustavsson et al[86](#tra12670-bib-0086){ref-type="ref"}
                                Mouse adipocytes                                                             RNAi by lentivirus                                                                        Caveolin‐1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3‐L1 adipocytes                                                                                                                                        Gonzalez‐Munoz et al[89](#tra12670-bib-0089){ref-type="ref"}
  *Rho A*                       *D. melanogaster*                                                            RNAi                                                                                      Increase of whole body fat content                                                                                                                                                                                                                         Baumbach et al[138](#tra12670-bib-0138){ref-type="ref"}
                                *C. elegans*                                                                 RNAi                                                                                      Increase of whole body fat content                                                                                                                                                                                                                         Webster et al[134](#tra12670-bib-0134){ref-type="ref"}
                                Mice                                                                         Activation                                                                                Lipid‐induced muscle insulin resistance through activation of the RhoA/Rho kinase signaling pathway                                                                                                                                                        Tao et al[147](#tra12670-bib-0147){ref-type="ref"}
                                Mice                                                                         Inhibitor                                                                                 Rho‐kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway                                                                                                                                                                   Noda et al[149](#tra12670-bib-0149){ref-type="ref"}
                                Rats                                                                         Activation through exercise                                                               Short‐term exercise increased insulin sensitivity and glucose tolerance through increased Rock activity and pIRS1                                                                                                                                          Muñoz et al[150](#tra12670-bib-0150){ref-type="ref"}
  *CDC42*                       *D. melanogaster*                                                            RNAi                                                                                      Hyperglycemia                                                                                                                                                                                                                                              Ugrankar et al[139](#tra12670-bib-0139){ref-type="ref"}
                                Human islets                                                                 Activation                                                                                Restoration of glucose‐stimulated Cdc42‐Pak1 activation and insulin secretion by a selective Epac activator in type 2 diabetic human islets                                                                                                                Veluthakal et al[64](#tra12670-bib-0064){ref-type="ref"}
                                Human islets; mouse islets; mouse pancreatic cell lines                      Review                                                                                    Cdc42: a novel regulator of insulin secretion and diabetes‐associated diseases                                                                                                                                                                             Huang et al[151](#tra12670-bib-0151){ref-type="ref"}
                                Wistar rats, STZ and HFD diet                                                Expression analysis                                                                       Increased cardiac expression of Cdc42 and Pak1 in diabetic hearts and in HG‐treated cardiomyocytes                                                                                                                                                         Raut et al[148](#tra12670-bib-0148){ref-type="ref"}
                                Mouse islets                                                                 RNAi                                                                                      Glucose‐stimulated Cdc42 signaling is essential for the second phase of insulin secretion                                                                                                                                                                  Wang et al[63](#tra12670-bib-0063){ref-type="ref"}
  *Rab5*                        *C. elegans*                                                                 RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Mukhopadhyay et al[140](#tra12670-bib-0140){ref-type="ref"}; Webster et al[134](#tra12670-bib-0134){ref-type="ref"}
                                *C. elegans*                                                                 RNAi                                                                                      Abnormal fat localization                                                                                                                                                                                                                                  Mukhopadhyay et al[140](#tra12670-bib-0140){ref-type="ref"}
                                *C. elegans*                                                                 RNAi                                                                                      Increase glucose metabolism                                                                                                                                                                                                                                Lee et al[132](#tra12670-bib-0132){ref-type="ref"}
                                *D. melanogaster*                                                            RNAi                                                                                      Hyperglycemia                                                                                                                                                                                                                                              Ugrankar et al[139](#tra12670-bib-0139){ref-type="ref"}
                                Mice                                                                         RNAi liver                                                                                Rab5 KD leads to loss of the endo‐lysosomal system and to the accumulation of glycogen                                                                                                                                                                     Zeigerer et al[7](#tra12670-bib-0007){ref-type="ref"}
                                Mice                                                                         RNAi liver                                                                                Regulation of liver metabolism by the endosomal GTPase Rab5. Rab5 KD mimics Van Gierke\'s disease                                                                                                                                                          Zeigerer et al[8](#tra12670-bib-0008){ref-type="ref"}
                                3T3‐L1 adipocytes                                                            Transfected with GFP‐Rab5                                                                 Rab5 is necessary for GLUT4 internalization                                                                                                                                                                                                                Huang et al[32](#tra12670-bib-0032){ref-type="ref"}
                                3T3‐L1 adipocytes                                                            Overexpression of SN (DN) mutant                                                          Rab5 activity regulates GLUT4 sorting                                                                                                                                                                                                                      Tessneer et al[33](#tra12670-bib-0033){ref-type="ref"}
                                Mouse liver                                                                  Recruitment                                                                               PI3K‐C2g is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signaling                                                                                                                                              Braccini et al[152](#tra12670-bib-0152){ref-type="ref"}
  *VPS34 (PI3K)*                *C. elegans*                                                                 RNAi                                                                                      Alteration of lipid metabolism                                                                                                                                                                                                                             Lapierre et al[141](#tra12670-bib-0141){ref-type="ref"}
                                Mice                                                                         Vps34 floxed mice                                                                         Liver‐specific albumin‐Cre; Vps34f/f mice develop hepatomegaly and hepatic steatosis, and impaired protein turnover                                                                                                                                        Jaber et al[127](#tra12670-bib-0127){ref-type="ref"}
                                Mice                                                                         Mutant                                                                                    Heterozygous Vps34 kinase‐dead mice show alterations in cellular energy metabolism, activating the AMPK pathway in liver and muscle                                                                                                                        Bilanges et al[112](#tra12670-bib-0112){ref-type="ref"}
  *Vps15 (PI3K)*                *C. elegans*                                                                 RNAi                                                                                      Reduction of whole body fat content. Abnormal lipid metabolism                                                                                                                                                                                             Ashrafi et al[136](#tra12670-bib-0136){ref-type="ref"}
                                Hepatocellular carcinoma Hepa1.6 cells; primary hepatocytes; Vps15f/f mice   RNAi                                                                                      Acute and chronic depletion of hepatic Vps15 increases insulin sensitivity and Akt signaling leading to alleviation of the metabolic syndrome in genetic and diet‐induced models of insulin resistance and diabetes                                        Nemazanyy et al[113](#tra12670-bib-0113){ref-type="ref"}
  *VPS45*                       3T3‐L1 adipocytes                                                            Expression and RNAi                                                                       Sorting of GLUT4 into its insulin‐sensitive store requires the Sec1/Munc18 protein mVps45                                                                                                                                                                  Roccisana et al[153](#tra12670-bib-0153){ref-type="ref"}
                                Skeletal muscle                                                              o/e and RNAi                                                                              **C**onditional deletion of APPL2 in skeletal muscles enhances insulin sensitivity, leading to an improvement in glucose tolerance                                                                                                                         Cheng et al[109](#tra12670-bib-0109){ref-type="ref"}
                                Diabetic patients                                                            Mutants                                                                                   Loss‐of‐function mutations in APPL1 in familial diabetes mellitus                                                                                                                                                                                          Prudente et al[16](#tra12670-bib-0016){ref-type="ref"}
                                L6 myoblasts and myotubes, C2C12 myoblasts                                   o/e and RNAi                                                                              APPL1 binds to adiponectin receptors and mediates adiponectin signaling and function                                                                                                                                                                       Mao et al[104](#tra12670-bib-0104){ref-type="ref"}
                                Pancreatic islets                                                            APPL1 KO mice                                                                             Deletion of the Appl1 gene leads to impairment of both the first and second phases of insulin secretion                                                                                                                                                    Wang et al[158](#tra12670-bib-0158){ref-type="ref"}
                                Rat hepatocytes and liver                                                    o/e and RNAi                                                                              APPL1 increases hepatic insulin sensitivity by potentiating insulin‐mediated suppression of the gluconeogenic program                                                                                                                                      Cheng et al[107](#tra12670-bib-0107){ref-type="ref"}
                                Human livers                                                                 SNP analysis                                                                              Association of genetic variation in adaptor protein APPL1/APPL2 loci with non‐alcoholic fatty liver disease                                                                                                                                                Barbieri et al[17](#tra12670-bib-0017){ref-type="ref"}
  *Rab4b*                       *Helicoverpa armigera*                                                       RNAi                                                                                      Decrease glycogen whole body content. Increase the transcription of FOXO                                                                                                                                                                                   Hou et al[142](#tra12670-bib-0142){ref-type="ref"}
  *AP1G1*                       *C. elegans*                                                                 RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Webster et al[134](#tra12670-bib-0134){ref-type="ref"}
  *Rab35*                       3T3‐L1 adipocytes                                                            o/e of DN Rab35                                                                           TBC1D13 is a Rab35 specific gap that plays an important role in Glut4 trafficking in adipocytes                                                                                                                                                            Davey et al[43](#tra12670-bib-0043){ref-type="ref"}
  *Rab11‐FIP3*                  *D. melanogaster*                                                            RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Pospisilik et al[135](#tra12670-bib-0135){ref-type="ref"}
  *VPS51 (GARP/EARP)*           *Danio rerio*                                                                Mutant                                                                                    Defect in glucose homeostasis                                                                                                                                                                                                                              Liu et al[143](#tra12670-bib-0143){ref-type="ref"}
  *VPS54 (GARP)*                *C. elegans*                                                                 RNAi                                                                                      Reduction of whole body fat content. Abnormal lipid metabolism                                                                                                                                                                                             Ashrafi et al[136](#tra12670-bib-0136){ref-type="ref"}
                                Mice                                                                         Spontaneous recessive point mutation in Vps54                                             The wobbler mouse is associated with a dysregulation of energy metabolism                                                                                                                                                                                  Schmitt‐John et al[80](#tra12670-bib-0080){ref-type="ref"}; Moser et al[81](#tra12670-bib-0081){ref-type="ref"}
  *VPS53 (GARP)*                Mouse and human cell lines and mice                                          RNAi, Vps54 mutant                                                                        The GARP complex is involved in intracellular cholesterol transport                                                                                                                                                                                        Wei et al[78](#tra12670-bib-0078){ref-type="ref"}
  *COMMD1 (CCC)*                Mice                                                                         Whole body KO                                                                             Lethal                                                                                                                                                                                                                                                     Van de Sluis[159](#tra12670-bib-0159){ref-type="ref"}
                                Mice                                                                         Liver‐specific KO                                                                         Hepatic copper accumulation and hypercholesterolemia                                                                                                                                                                                                       Vonk et al[75](#tra12670-bib-0075){ref-type="ref"}; Bartuzi et al[71](#tra12670-bib-0071){ref-type="ref"}
                                Dogs                                                                         Whole body deficiency                                                                     Hepatic copper storage disorder and hypercholesterolemia                                                                                                                                                                                                   Bartuzi et al[71](#tra12670-bib-0071){ref-type="ref"}
  *COMMD6* and *COMMD9 (CCC)*   Mice                                                                         Liver‐specific KO                                                                         Hypercholesterolemia                                                                                                                                                                                                                                       Fedoseienko et al[10](#tra12670-bib-0010){ref-type="ref"}
  *CCDC22 (CCC)*                Patients (X‐linked intellectual disability)                                  Hypomorphic mutation                                                                      Hypercholesterolemia                                                                                                                                                                                                                                       Bartuzi et al[71](#tra12670-bib-0071){ref-type="ref"}
  *WASH*                        Mouse and human cell lines                                                   RNAi                                                                                      WASH complex is needed to efficiently recycle the nutrient transporters GLUT1 (also known as SLC2A1) and SLC1A4, and potentially many other surface proteins                                                                                               Kvainickas et al[52](#tra12670-bib-0052){ref-type="ref"}
                                Patients, dogs, liver                                                        Liver‐specific KO                                                                         CCC‐ and WASH‐mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL                                                                                                                                                       Bartuzi et al[71](#tra12670-bib-0071){ref-type="ref"}
                                Primary hepatocytes, liver, adipocytes                                       Whole body; liver‐ and adipocyte‐specific Pid1‐deficient mice                             The adaptor protein PID1 regulates receptor dependent endocytosis of postprandial triglyceride‐rich lipoproteins, and whole body glucose homeostasis                                                                                                       Fischer et al[77](#tra12670-bib-0077){ref-type="ref"}; Chen et al[76](#tra12670-bib-0076){ref-type="ref"}
  *WASHC1 (WASH)*               Mouse embryonic fibroblast                                                   KO                                                                                        Impaired LDLR trafficking, reduced LDLR uptake                                                                                                                                                                                                             Bartuzi et al[71](#tra12670-bib-0071){ref-type="ref"}
                                Pancreas                                                                     Conditional KO                                                                            WASH regulates glucose homeostasis by facilitating Glut2 receptor recycling in pancreatic beta cells                                                                                                                                                       Ding et al[62](#tra12670-bib-0062){ref-type="ref"}
  *WASHC5 (WASH)*               Patients (RSS)                                                               Mutation                                                                                  High plasma LDL‐C                                                                                                                                                                                                                                          Bartuzi et al[71](#tra12670-bib-0071){ref-type="ref"}
  *Retromer complex*            Human cells                                                                  Interaction and infection                                                                 PTEN regulates glucose transporter recycling by impairing SNX27 retromer assembly                                                                                                                                                                          Shinde and Maddika[53](#tra12670-bib-0053){ref-type="ref"}
                                3T3‐L1 adipocytes                                                            KD                                                                                        VPS35 (retromer) regulates GLUT4 trafficking                                                                                                                                                                                                               Pan et al[162](#tra12670-bib-0162){ref-type="ref"}; Yang et al[161](#tra12670-bib-0161){ref-type="ref"}
                                Human renal proximal tubule cells, rat and mouse kidneys                     RNAi                                                                                      Loss of renal SNX5 results in impaired IDE activity and insulin resistance in mice                                                                                                                                                                         Li et al[160](#tra12670-bib-0160){ref-type="ref"}
  *COPI*                        *C. elegans*                                                                 RNAi                                                                                      Increase glucose metabolism                                                                                                                                                                                                                                Lee et al[132](#tra12670-bib-0132){ref-type="ref"}
  *VPS33A/B (CORVET /HOPS)*     *D. melanogaster*                                                            RNAi                                                                                      Increase of whole body fat content                                                                                                                                                                                                                         Baranski et al[144](#tra12670-bib-0144){ref-type="ref"}
                                Patients                                                                     Expression/mutation analysis and patient characterization                                 Patients with Vps33b mutations in the ARC syndrome show cholestasis, metabolic acidosis, nephrogenic diabetes insipidus, chronic diarrhea, platelet abnormalities, and central nervous system anomalies                                                    Jang et al[154](#tra12670-bib-0154){ref-type="ref"}
                                Mice                                                                         Vps33bfl/fl‐AlfpCre KO                                                                    Vps33b is crucial for structural and functional hepatocyte polarity and defects of lipid metabolism                                                                                                                                                        Hanley et al[155](#tra12670-bib-0155){ref-type="ref"}
  *VPS16 (CORVET /HOPS)*        *C. elegans*                                                                 RNAi                                                                                      Increase glucose metabolism                                                                                                                                                                                                                                Lee et al[132](#tra12670-bib-0132){ref-type="ref"}
  *VPS18 (CORVET)*              *D. melanogaster*                                                            RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Baumbach et al[138](#tra12670-bib-0138){ref-type="ref"}
  *Rab7*                        *C. elegans*                                                                 RNAi                                                                                      Abnormal lipid metabolism                                                                                                                                                                                                                                  Ashrafi et al[136](#tra12670-bib-0136){ref-type="ref"}
                                *C. elegans*                                                                 RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Mukhopadhyay et al[140](#tra12670-bib-0140){ref-type="ref"}; Ashrafi et al[136](#tra12670-bib-0136){ref-type="ref"}
                                *D. melanogaster*                                                            RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Baumbach et al[138](#tra12670-bib-0138){ref-type="ref"}
                                Hepatic cells                                                                RNAi                                                                                      The Small GTPase Rab7 as a central regulator of hepatocellular lipophagy                                                                                                                                                                                   Schroeder et al[126](#tra12670-bib-0126){ref-type="ref"}
  *VPS28 (ESCRT I)*             *D. melanogaster*                                                            RNAi                                                                                      Increase of whole body fat content                                                                                                                                                                                                                         Baumbach et al[138](#tra12670-bib-0138){ref-type="ref"}
                                *D. melanogaster*                                                            RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Pospisilik et al[135](#tra12670-bib-0135){ref-type="ref"}
                                Mouse and monkey                                                             Activation through enhanced ubiquitination                                                Tmbim1 is a multivesicular body regulator that protects against non‐alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4                                                                                       Zhao et al[125](#tra12670-bib-0125){ref-type="ref"}
                                Mouse and human cell lines                                                   siRNA against ESCRT‐0 (STAM1), ESCRT‐I (UBAP1), ESCRT‐II (Vps22), or ESCRT‐III (CHMP4C)   The endosomal sorting complex required for transport pathway mediates chemokine receptor CXCR4‐promoted lysosomal degradation of the mammalian target of rapamycin antagonist DEPTOR                                                                       Verma and Marchese[156](#tra12670-bib-0156){ref-type="ref"}
  *VPS36 (ESCRT II)*            *D. melanogaster*                                                            RNAi                                                                                      Increase of whole body fat content                                                                                                                                                                                                                         Baumbach et al[138](#tra12670-bib-0138){ref-type="ref"}
  *Chmp3 (ESCRT III)*           *D. melanogaster*                                                            RNAi                                                                                      Increase of whole body fat content                                                                                                                                                                                                                         Baumbach et al[138](#tra12670-bib-0138){ref-type="ref"}
                                *C. elegans*                                                                 RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Ashrafi et al[136](#tra12670-bib-0136){ref-type="ref"}
                                Rat adipocytes                                                               DN inhibitor constructs                                                                   GLUT4 traffic through an ESCRT‐III‐dependent sorting compartment in adipocytes                                                                                                                                                                             Koumanov et al[157](#tra12670-bib-0157){ref-type="ref"}
                                Mice                                                                         Promotor analysis                                                                         Identification of genetic elements in Chmp3 that are associated with metabolic diseases by high‐throughput mouse phenotyping                                                                                                                               Rozman et al[131](#tra12670-bib-0131){ref-type="ref"}
  *Chmp4c (ESCRT III)*          *C. elegans*                                                                 RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Webster et al[134](#tra12670-bib-0134){ref-type="ref"}
                                Mouse and human cell lines                                                   siRNA against ESCRT‐0 (STAM1), ESCRT‐I (UBAP1), ESCRT‐II (Vps22), or ESCRT‐III (CHMP4C)   The endosomal sorting complex required for transport pathway mediates chemokine receptor CXCR4‐promoted lysosomal degradation of the mammalian target of rapamycin antagonist DEPTOR                                                                       Verma and Marchese[156](#tra12670-bib-0156){ref-type="ref"}
  *Chmp1 (ESCRT III)*           *D. melanogaster*                                                            RNAi                                                                                      Increase of whole body fat content                                                                                                                                                                                                                         Baumbach et al[138](#tra12670-bib-0138){ref-type="ref"}
  *Vps4*                        *D. melanogaster*                                                            RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Baumbach et al[138](#tra12670-bib-0138){ref-type="ref"}
                                Rat adipocytes                                                               DN inhibitor constructs                                                                   GLUT4 traffic through an ESCRT‐III‐dependent sorting compartment in adipocytes                                                                                                                                                                             Koumanov et al[157](#tra12670-bib-0157){ref-type="ref"}
  *VAMP3*                       *C. elegans*                                                                 RNAi                                                                                      Reduction of whole body fat content. Abnormal lipid metabolism                                                                                                                                                                                             Ashrafi et al[136](#tra12670-bib-0136){ref-type="ref"}
  *Exoc6 (exocyst)*             *D. melanogaster*                                                            RNAi                                                                                      Reduction of whole body fat content                                                                                                                                                                                                                        Baumbach et al[138](#tra12670-bib-0138){ref-type="ref"}
  *Rab10*                       3T3‐L1 adipocytes                                                            RNAi                                                                                      SEC16A is a RAB10 effector required for insulin‐stimulated GLUT4 trafficking in adipocytes                                                                                                                                                                 Bruno et al[45](#tra12670-bib-0045){ref-type="ref"}
                                Mice                                                                         Rab10 KO                                                                                  The small Rab GTPase, Rab10, is required for insulin‐stimulated GLUT4 translocation in cultured 3T3‐L1 adipocytes                                                                                                                                          Vazirani et al[44](#tra12670-bib-0044){ref-type="ref"}
                                3T3‐L1 adipocytes                                                            o/e CA Rab10 and RNAi                                                                     Rab10, a target of the AS160 Rab GAP, is required for insulin‐stimulated translocation of GLUT4 to the adipocyte plasma membrane                                                                                                                           Sano et al[41](#tra12670-bib-0041){ref-type="ref"}
  Munc18c                       Mice                                                                         Heterozygous KO                                                                           Altered Glut4 translocation in muscle; defect of beta‐cells insulin secretion; severe glucose intolerance                                                                                                                                                  Oh et al[48](#tra12670-bib-0048){ref-type="ref"}

Despite the recent advances in technology to study both endocytosis and metabolism in great detail, there is still little information on how these two modules are connected. These gaps in knowledge can be largely explained by two main limitations in current research that should be addressed. Firstly, endosomal trafficking and metabolism are mainly studied independently of each other, largely due to the complexity of both processes. Therefore, basic scientists and clinicians of even closely related fields often use different terminology and concepts, leading to an impression of speaking different "languages." This makes the understanding and appreciation of each other\'s work challenging. Secondly, endosomal transport processes are mainly studied in cells (in vitro systems). Basic knowledge obtained through these in vitro studies is rarely followed up by studies in mouse models and in humans (clinical samples), which hampers the translation of fundamental knowledge on endosomal transport into (patho‐) physiological information and also potential clinical relevance. This is largely explained by the limited number of model systems available to study the endosomal system at an organismal level. Furthermore, a lot of sophisticated technologies are mainly applied to in vitro systems and not to in vivo systems, because of their restrictions, high costs or lack of knowledge regarding how to use them in more complex model systems (eg, organoids and animal models). While the connection between endocytosis and gluco‐lipid metabolism is becoming more evident, fruitful collaborations with other scientists equipped with animal facilities and established primary cell culture systems will enable a more in vivo oriented characterization of endosomal transport in metabolic control. In addition, shared conferences and research consortia could be initiated to bring together scientists from both fields for discussions, exchange and inspiration. Apart from the collaborations that could arise from such initiatives, this would also help to establish a common language and understanding in the field.

There are many open questions that could be addressed following such a strategy. For instance, what is the function of the endosomal system in different metabolically active tissues? We have seen already that adipose and liver tissue fulfill very different functions. Further work should therefore extend and deepen these initial insights. Likewise, what is the function of the endosomal system in cells with minimal direct contribution to whole body energy metabolism? We recently demonstrated that depleting Rab4b in T cells was sufficient to alter adipose tissue function leading to liver steatosis and insulin resistance.[34](#tra12670-bib-0034){ref-type="ref"} Is the recycling of cargo through the retriever pathway, as shown for LDLR in the liver, similar in fat? The interesting data on the role of the WASH complex on GLUT2 trafficking opens up the possibility of a potential function of the retriever‐CCC‐WASH complex on GLUT4 in vivo, as has been suggested from adipocyte cell lines.[161](#tra12670-bib-0161){ref-type="ref"}, [162](#tra12670-bib-0162){ref-type="ref"} Also, is the control of signaling through the endosomal system comparable between muscle and liver? For instance, AKT2 activation induces very different responses in the muscle, where it induces glucose uptake, than in the liver, where it represses gluconeogenesis. The conflicting data on APPL1 and APPL2 in these tissues could be examples of tissue‐specific regulation.

Interestingly, we also presented evidence that components of the endosomal system are altered upon different metabolic challenges and in metabolic diseases, such as type 2 diabetes and NAFLD. Further studies are necessary to elucidate the mechanisms underlying these observations. This would require culturing cells in more physiological conditions (between 5 and 11 mM glucose, which corresponds to 90 and 200 mg/dL blood glucose concentration, respectively) rather than exposing them to extremely high glucose levels of usually 25 mM, which translates into 450 mg/dL blood glucose values, usually only observed in severely diabetic and obese mice. Metabolically active cells will respond, when primed. For instance, studies in yeast have already shown that high glucose stimulations induce the assembly of adapters and clathrin on the TGN and endosomes.[163](#tra12670-bib-0163){ref-type="ref"} In addition, expression analysis and functional assays can be performed in human tissues and mouse models of metabolic disease, respectively, to elucidate whether endosomal components and endocytosis functions properly in a diabetic or obese condition. There are many more endosomal components waiting to be studied, where exciting new functions of these components and endocytosis per se in metabolic control can be explored and unraveled. There are exciting times ahead for this emerging field.
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